Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.2.0.727
Consolidated Statements of Operations - Entity [Domain] - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
General and administrative expenses 813,122 825,951 2,536,654 2,271,443
Research and development expenses 525,107 320,345 1,327,337 951,101
Total operating expenses 1,338,229 1,146,296 3,863,991 3,222,544
Operating loss (1,338,229) (1,146,296) (3,863,991) (3,222,544)
Other income (expense):        
Interest expense (134,326) (27,763) (212,647) (83,293)
Fair value of derivative liabilities in excess of proceeds 0 0 0 (7,541,693)
Gain on exercise of warrants 75,321 0 299,321 0
Gain/(loss) on warrant derivative modification 927,373 0 (996,813) 0
(Increase)/decrease to fair value of derivative (925,384) 1,584,818 2,924,064 2,069,693
Total other income (expense) (57,016) 1,557,055 2,013,925 (5,555,293)
Net (Loss)/income $ (1,395,245) $ 410,759 $ (1,850,066) $ (8,777,837)
Basic earnings per share        
Net (loss) income per common share basic $ (0.02) $ 0.01 $ (0.02) $ (0.13)
Weighted common shares - basic 76,804,674 71,949,564 75,396,047 65,933,378
Diluted earnings per share        
Net (loss) income per common share diluted $ (0.02) $ 0.01 $ (0.02) $ (0.13)
Weighted common shares - diluted 76,804,674 72,084,748 75,396,047 65,933,378